SCHEMBL208507

SCHEMBL208507

COc1ccc2[nH]cc(CCNC(=O)CCC(=O)NC3CCC(Cc4cccc(C)c4)(N(C)C)CC3)c2c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 6/20 0.59
BCHE P06276 4/20 0.59
MTNR1A P48039 6/20 0.53
MTNR1B P49286 5/20 0.53
ALDH1A1 P00352 2/20 0.51
LMNA P02545 1/20 0.50
SIGMAR1 Q99720 1/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
KDM4E B2RXH2 1/20 0.48
CYP1A1 P04798 1/20 0.48
MPO P05164 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
HTR1A P08908 1/20 0.48
CYP2D6 P10635 1/20 0.48
HPGD P15428 1/20 0.48
NQO2 P16083 1/20 0.48
HTR2B P41595 1/20 0.48
RAB9A P51151 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL207608 0.90 BCHE (0.56) ACHEBCHEMTNR1AMEN1KMT2A
SCHEMBL206020 0.81 ACHE (0.53) ACHEBCHEMTNR1AALDH1A1MEN1
SCHEMBL208817 0.80 NPC1 (0.47) ALDH1A1MEN1KMT2AKDM4ECYP1A2
SCHEMBL206736 0.80 HPGD (0.48) ALDH1A1LMNAMEN1KMT2AKDM4E
SCHEMBL208032 0.79 CDK4 (0.50) ACHEBCHEALDH1A1SIGMAR1HPGD
SCHEMBL205931 0.79 TSHR (0.40) ACHEBCHEALDH1A1LMNASIGMAR1
SCHEMBL206949 0.79 SIGMAR1 (0.54) ACHEBCHEMTNR1AMTNR1BALDH1A1
SCHEMBL205750 0.78 HPGD (0.39) LMNAMEN1KMT2AHPGDHSD17B10
SCHEMBL209344 0.78 ALDH1A1 (0.42) MTNR1AMTNR1BALDH1A1MEN1KMT2A
SCHEMBL205392 0.78 HPGD (0.46) ALDH1A1LMNASIGMAR1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088763-B2 e.g. N-[1-(2,6-dichloro-benzyl)-pyrrolidin-3-yl]-N'-[4-dimethylamino-4-(4-methyl-benzyl)-cyclohexyl]-succinamide; noradrenaline and serotonin reuptake ihibitor; opioid ORL-1 receptor ligand; analgesic, antidepressant, anxiolytic agent, neurodegenerative diseases GRUENENTHAL GMBH (DE) 2012-01-03 US claimed
EP-1745010-B1 SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2009-08-05 EP claimed
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds GRUENENTHAL GMBH (DE) 2007-05-17 US claimed
US-8088763-B2 e.g. N-[1-(2,6-dichloro-benzyl)-pyrrolidin-3-yl]-N'-[4-dimethylamino-4-(4-methyl-benzyl)-cyclohexyl]-succinamide; noradrenaline and serotonin reuptake ihibitor; opioid ORL-1 receptor ligand; analgesic, antidepressant, anxiolytic agent, neurodegenerative diseases GRUENENTHAL GMBH (DE) 2012-01-03 US disclosed
EP-1745010-B1 SUBSTITUTED CYCLOHEXYL-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2009-08-05 EP disclosed
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds GRUENENTHAL GMBH (DE) 2007-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070112007-A1 Cyclohexyl-1, 4-diamine compounds PKD1, DDC, DPYD ACHE 2158/4885BCHE 894/4885MTNR1A 3152/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.